These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3098877)

  • 21. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.
    Halla JT; Hardin JG; Linn JE
    Arthritis Rheum; 1977; 20(6):1188-91. PubMed ID: 409414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guillain-Barré syndrome secondary to chrysotherapy].
    Valdazo JP; Romero B; Orte J; Brito E
    Med Clin (Barc); 1990 Oct; 95(14):556. PubMed ID: 2128101
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term chrysotherapy in rheumatoid arthritis.
    Srinivasan R; Miller BL; Paulus HE
    Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute renal failure due to gold.
    Robbins G; McIllmurray MB
    Postgrad Med J; 1980 May; 56(655):366-7. PubMed ID: 6777766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gold myokymia syndrome. A rare toxic manifestation of chrysotherapy.
    Caldron PH; Wilbourn AJ; Bravo EE; Mitsumoto H
    Cleve Clin J Med; 1987; 54(3):225-8. PubMed ID: 3111748
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver dysfunction associated with gold therapy for rheumatoid arthritis.
    Edelman J; Donnelly R; Graham DN; Percy JS
    J Rheumatol; 1983 Jun; 10(3):510-1. PubMed ID: 6411922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse pulmonary injury associated with gold treatment.
    Winterbauer RH; Wilske KR; Wheelis RF
    N Engl J Med; 1976 Apr; 294(17):919-21. PubMed ID: 130554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogammaglobulinemia: a possible complication of chrysotherapy?
    Chaiamnuay P; Edelman J; Percy JS; Pabst HF
    J Rheumatol; 1983 Jun; 10(3):517-8. PubMed ID: 6411924
    [No Abstract]   [Full Text] [Related]  

  • 29. Skin reaction associated with chrysotherapy: an unusual case.
    Carlucci F; Chimenti MS; Priori R; Tentolini U; Marasco A; Valesini G
    Clin Exp Rheumatol; 2004; 22(1):136. PubMed ID: 15005022
    [No Abstract]   [Full Text] [Related]  

  • 30. [Case report and literature analysis of the clinical factors relating to the development of fibrotic changes in gold lung].
    Aoshiba K; Fukuda I; Mochizuki M; Tamaoki J; Konno K; Takizawa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):336-43. PubMed ID: 2113147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse pulmonary changes caused by gold salt therapy. Report of a case.
    Gortenuti G; Parrinello A; Vicentini D
    Diagn Imaging Clin Med; 1985; 54(6):298-303. PubMed ID: 3933883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal bronchiolitis obliterans associated with chrysotherapy.
    Holness L; Tenenbaum J; Cooter NB; Grossman RF
    Ann Rheum Dis; 1983 Oct; 42(5):593-6. PubMed ID: 6414389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary fibrosis associated with hypersensitivity to gold salts.
    Geddes DM; Brostoff J
    Br Med J; 1976 Jun; 1(6023):1444. PubMed ID: 821576
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary injury induced by gold salts treatment.
    Schapira D; Nahir M; Scharf Y
    Med Interne; 1985; 23(4):259-63. PubMed ID: 2935924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
    Lorber A; Atkins CJ; Chang CC; Lee YB; Starrs J; Bovy RA
    Ann Rheum Dis; 1973 Mar; 32(2):133-9. PubMed ID: 4632661
    [No Abstract]   [Full Text] [Related]  

  • 36. [Continuous chrysotherapy of rheumatoid disease (evaluation of a retrospective study of 42 cases)].
    D'eshougues JR; Delcambre B; Maquerlot M; Defrance D
    Lille Med; 1977; 22(7):430-8. PubMed ID: 412025
    [No Abstract]   [Full Text] [Related]  

  • 37. [A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].
    Usuba Y; Aiba S; Hashimoto K; Tanita Y; Sakai K
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):725-30. PubMed ID: 2511359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of IgE antibodies to sodium aurothiomalate and adverse reactions to chrysotherapy for rheumatoid arthritis.
    Bretza J; Wells I; Novey HS
    Am J Med; 1983 Jun; 74(6):945-50. PubMed ID: 6407306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematologic reactions to chrysotherapy treated with iv N-acetylcysteine.
    Taylor PW; Fischbein L
    J Rheumatol; 1984 Aug; 11(4):562-3. PubMed ID: 6434740
    [No Abstract]   [Full Text] [Related]  

  • 40. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.